X0306
4
2021-11-09
0
0001564406
Oak Street Health, Inc.
OSH
0001793313
PRICE GEOFFREY M
C/O OAK STREET HEALTH, INC.
30 W. MONROE ST., SUITE 1200
CHICAGO
IL
60603
1
1
0
0
Chief Operating Officer
Common Stock, $0.001 par value
2021-11-09
4
S
0
13637
37.014
D
2390433
I
By Price-Uhl Living Trust
Common Stock, $0.001 par value
2021-11-09
4
S
0
10791
37.991
D
2379642
I
By Price-Uhl Living Trust
Common Stock, $0.001 par value
2021-11-09
4
S
0
2772
38.914
D
2376870
I
By Price-Uhl Living Trust
Common Stock, $0.001 par value
2021-11-09
4
S
0
300
39.973
D
2376570
I
By Price-Uhl Living Trust
Common Stock, $0.001 par value
2021-11-09
4
S
0
100
43.88
D
2376470
I
By Price-Uhl Living Trust
Common Stock, $0.001 par value
2021-11-09
4
S
0
500
45.61
D
2375970
I
By Price-Uhl Living Trust
Common Stock, $0.001 par value
3796289
D
Common Stock, $0.001 par value
48
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) through (5) to this Form 4.
Transactions within a $1.00 price range are reported in accordance with the June 25th 2008 SEC No-Action letter. Minimum price was $36.50 and maximum price was $37.475.
Transactions within a $1.00 price range are reported in accordance with the June 25th 2008 SEC No-Action letter. Minimum price was $37.50 and maximum price was $38.49.
Transactions within a $1.00 price range are reported in accordance with the June 25th 2008 SEC No-Action letter. Minimum price was $38.55 and maximum price was $39.42.
Transactions within a $1.00 price range are reported in accordance with the June 25th 2008 SEC No-Action letter. Minimum price was $39.81 and maximum price was $40.07.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
/s/ Robert Guenthner, attorney-in-fact for Geoffrey Price
2021-11-10